SecBot SecBot
144 ·Filed Aug 26, 2026

PGEN

PRECIGEN, INC.
NEUTRAL
Impact 3/10
Horizondays Processed2mo ago SEC0001958244-26-000558
Form 144, notice of proposed sale of securities
Actionable Insight • Neutral

This is a routine diversification sale by a director, not a CEO/CFO, and the dollar amount is small relative to market cap. The strong institutional accumulation and bullish analyst consensus suggest no fundamental concern. Monitor for any Form 4 filings confirming execution, but no immediate trading action is warranted.

DirectionNeutral
Confidencemedium
Horizondays

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+20
Entry
$7.19
T+0 close · Aug 26, 2026 · via day close
Latest settled
+7.09%
T+20 · $7.70 · next T+60 in 3d
Vs SPY
+7.60%
α at T+20
Latest observation
−20.96%
T+55 · FF3 residual α
  1. T+0 · Aug 27 $7.19entry
  2. T+1 · 3mo ago −3.34%α −3.11% · $6.95
  3. T+5 · 3mo ago −0.70%α −0.96% · $7.14
  4. T+20 · 8w ago +7.09%α +7.60% · $7.70
  5. T+56 · todayOpen
  6. T+60 · in 3d Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Director Jeffrey Kindler filed a Form 144 to sell 185,000 shares of Precigen (PGEN) at an estimated aggregate value of $1,372,700. The shares were acquired through restricted stock unit vestings from 2023 to 2026. While the sale is modest relative to the company's $2.6B market cap, it comes amid a period of heavy institutional accumulation and a 78% bullish analyst consensus, making the timing notable but not alarming for a director-level diversification trade.

Key Facts

  • Director Jeffrey Kindler filed Form 144 to sell 185,000 shares of Precigen (PGEN).
  • Estimated aggregate sale value is $1,372,700.
  • Shares were acquired via restricted stock unit vestings on 03/09/2023, 03/09/2024, 03/13/2025, 03/13/2026, and 03/10/2026.
  • The sale is being executed through Goldman Sachs & Co. LLC.
  • PGEN has a market cap of $2.6B and 78% analyst bullish consensus (7 Buy/Strong Buy, 2 Hold).
  • Recent insider activity (30d) shows 2 sells totaling $709K, and this filing adds a third.
  • Institutional 13F data shows strong accumulation: 4 funds doubled positions, 11 added, only 3 trimmed.

Financial Impact

Director selling 185,000 shares worth ~$1.37M, representing approximately 0.05% of market cap

dilutioninsider ownership

Risk Factors

  • Insider selling could signal reduced conviction if followed by additional director sales
  • Form 144 is an intent to sell, actual sale may not occur, but the filing itself signals the insider considered selling

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
78% bullish (9 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001958244-26-000558
Document: 0001958244-26-000558-index.html0001958244-26-000558
Document: 0001958244-26-000558.txt0001958244-26-000558

Track record

13 reports on PGEN

Performance horizon

3 of 4 bullish or bearish reports moved the stock their way by T+5. Best: +52.17% at T+60 after the May 13, 2026 report. 4 of 4 went positive at some point.

Filters
  1. Nov 4, 202612d ago 8-K Bullish 6/10 Entry $4.22 to $4.66 Now $4.30 +1.90% ▲ +10.43% +7.14% vs SPY
  2. Aug 28, 202611w ago Insider Cluster Neutral 3/10 Entry $6.93 to $6.99 Now $4.30 −37.95% ▲ +0.79% +0.94% vs SPY
  3. Aug 26, 202611w ago 144 Neutral 3/10 Viewing Entry $7.19 to $7.14 Now $4.30 −40.19% ▼ −0.70% −0.96% vs SPY
  4. Aug 25, 202611w ago Insider Cluster Bearish 4/10 Entry $7.42 to $7.01 Now $4.30 +42.05% ▲ +5.53% +5.41% vs SPY
  5. Aug 25, 202611w ago Insider Cluster Neutral 2/10 Entry $7.42 to $7.01 Now $4.30 −42.05% ▼ −5.53% −5.41% vs SPY
  6. Aug 7, 202614w ago Insider Cluster Neutral 2/10 Entry $7.00 to $6.55 Now $4.30 −38.57% ▼ −6.43% −6.38% vs SPY
  7. Aug 3, 202615w ago Insider Cluster Neutral 2/10 Entry $6.53 to $6.86 Now $4.30 −34.15% ▲ +5.05% +5.15% vs SPY
  8. Jul 1, 202619w ago Insider Cluster Bearish 5/10 Entry $5.64 to $5.53 Now $4.30 +23.76% ▲ +1.95% +2.88% vs SPY
  9. Jun 24, 202620w ago 8-K Neutral 3/10 Entry $5.52 to $5.25 Now $4.30 −22.10% ▼ −4.89% −6.45% vs SPY
  10. Jun 1, 202624w ago Insider Cluster Neutral 3/10 Entry $3.86 to $3.71 Now $4.30 +11.40% ▼ −3.89% −0.92% vs SPY
Showing 10 of 13

US Market Status

Market Closed · Opens in 6h 39m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 26, 2026